YL 0919
YL 0919 Basic information
- Product Name:
- YL 0919
- Synonyms:
-
- YL0919 hydrochloride
- CS-2407
- YL0919 (YL-0919
- 0919
- Hypidone hydrochloride
- Inhibitor,5-hydroxytryptamine Receptor,Serotonin Receptor,5-HT Receptor,Hypidone,Hypidone hydrochloride,YL 0919,inhibit,YL-0919
- 1-((1-Benzyl-4-hydroxypiperidin-4-yl)methyl)pyridin-2(1H)-one hydrochloride
- Hypidone hydrochloride, 10 mM in DMSO
- CAS:
- 1339058-04-6
- MF:
- C18H23ClN2O2
- MW:
- 334.84
- Mol File:
- 1339058-04-6.mol
YL 0919 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO : ≥ 30 mg/mL (89.60 mM)
- form
- Solid
- color
- White to off-white
YL 0919 Usage And Synthesis
Uses
Hypidone hydrochloride (YL0919) is an orally active antidepressant agent with dual activity as a highly seletive 5-HT uptake blocker and an effective 5-HT1A receptor agonist (Ki=0.19 nM). Hypidone hydrochloride inhibits the uptake of [3H]-5-HT into rat cerebral cortical synaptosomes and HEK293 cells with IC50s of 1.78 nM and 1.93 nM, respectively. Hypidone hydrochloride shows remarkable antidepressant effects in animal models and has the poential for the investigation of depressive disorder[1].
in vivo
Hypidone hydrochloride (YL0919) (oral administration; 1.25 or 5 mg/kg; 4 weeks) and fluoxetine (10 mg/kg) reverses the inhibition of locomotor activity in CUS rats[1].Hypidone hydrochloride (oral administration; 1.25, 2.5, and 5 mg/kg; 4 weeks) significantly reduces the immobility time in TST in mcie FST in mice. Besides, Hypidone hydrochloride displays no effect on the locomotor activity in a separate OFT. Furthermore, the antidepressant-like effect of Hypidone hydrochloride in TST and FST is completely bunted by coadministration with WAY-100635[1].
| Animal Model: | Male ICR mice weighing 18–22 g[1] |
| Dosage: | 1.25, 2.5, and 5 mg/kg |
| Administration: | Oral administration |
| Result: | Had an effect on Antidepressant-like mice in TST and FST. |
IC 50
5-HT1A Receptor
References
[1] Chen, H. X. et al. Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist. PloS one 8, e83271, doi:10.1371/journal.pone.0083271 (2013). DOI:10.1371/journal.pone.0083271
[2] Qin, J. J. et al. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor. Neuroscience letters 582, 104-108, 2014.09.009 (2014)
YL 0919Supplier
- Tel
- 021-52996696，15000506266 15000506266
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 15076683720
- klq@cw-bio.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 0-2022843681 15618226720
- chaolaichem@foxmail.com